3 Axis Advisors(@3AxisAdvisors) 's Twitter Profileg
3 Axis Advisors

@3AxisAdvisors

3 Axis Advisors specializes in the disruptive simplification of the prescription drug supply chain.

ID:1088265347894071297

linkhttps://www.3axisadvisors.com/ calendar_today24-01-2019 02:40:52

329 Tweets

770 Followers

119 Following

Follow People
3 Axis Advisors(@3AxisAdvisors) 's Twitter Profile Photo

“What makes this situation unique is that CVS has not selected the cheapest product, so it’s ‘propping up a more inflated version than what the marketplace is otherwise bearing.’”

endpts.com/sandozs-humira… Zach Brennan Antonio Ciaccia Mark Cuban Mark Cuban Cost Plus Drug Company

account_circle
The Hill Events(@TheHillEvents) 's Twitter Profile Photo

'What we were seeing in the state of Ohio was that pharmacies were getting paid less and less for the medicines that they were dispensing to their, Medicaid beneficiaries. But on the other end of the transaction, as those cuts were occurring, the state of Ohio was spending more…

account_circle
The Hill Events(@TheHillEvents) 's Twitter Profile Photo

'How can we continue to provide benefits in a system where the vendor's incentives are in direct conflict with that of the plan sponsor and the patient? You know, the theme here is transparency.' - Antonio Ciaccia, President, 3 Axis Advisors

To watch the full event visit:…

account_circle
Antonio Ciaccia(@A_Ciaccia) 's Twitter Profile Photo

Was great to attend @TheHill’s Prescribing PBM Reform summit last week and talk shop with some of the brightest minds in the drug policy world. thehill.com/events/4485333…

Was great to attend @TheHill’s Prescribing PBM Reform summit last week and talk shop with some of the brightest minds in the drug policy world. thehill.com/events/4485333…
account_circle
3 Axis Advisors(@3AxisAdvisors) 's Twitter Profile Photo

“You can add lawsuits like this to the mountain of reasons to create greater clarity, guardrails, and accountability within the 340B program.” - Antonio Ciaccia

statnews.com/pharmalot/2024… pharmalot ed silverman

account_circle
3 Axis Advisors(@3AxisAdvisors) 's Twitter Profile Photo

“The thing that makes us most unique is this kickback scheme that ultimately enables and rewards intermediaries and middlemen at the expense of the end-paying consumer.” - Antonio Ciaccia

abc6onyourside.com/news/local/in-… Darrel Rowland WSYX ABC 6

account_circle
3 Axis Advisors(@3AxisAdvisors) 's Twitter Profile Photo

Merck, J&J and Bristol Myers CEOs face drug-pricing grilling on Capitol Hill, but experts cite deeper problems under the radar Eleanor Laise Antonio Ciaccia Adam J. Fein marketwatch.com/story/merck-j-…

account_circle
3 Axis Advisors(@3AxisAdvisors) 's Twitter Profile Photo

Pharmacy benefits contractor for West Virginia public employees system pays itself way more for some drugs than necessary Marty Schladen Mark Cuban Cost Plus Drug Company ohiocapitaljournal.com/2024/02/06/con…

account_circle
3 Axis Advisors(@3AxisAdvisors) 's Twitter Profile Photo

This week, Antonio Ciaccia joined CBS Detroit to discuss federal efforts to combat rising prescription drug costs and why big PBMs are under fire for their role in undermining traditional market forces that could yield better savings for consumers. cbsnews.com/detroit/video/…

account_circle
3 Axis Advisors(@3AxisAdvisors) 's Twitter Profile Photo

“That’s the sad part about this system. Formularies are often used to direct patients to medicines that might actually be more expensive for them, in order to generate rebates that accrue to others.” - Antonio Ciaccia

managedhealthcareexecutive.com/view/2024-form… Denise Myshko Managed Healthcare Mark Cuban

account_circle
Reuters Health(@Reuters_Health) 's Twitter Profile Photo

Excluding different doses and formulations, more than 140 brands of drugs will have their prices raised, data analyzed by healthcare research firm 3 Axis Advisors showed. reut.rs/47jwfjx reut.rs/47jwfjx

account_circle
Antonio Ciaccia(@A_Ciaccia) 's Twitter Profile Photo

Great use of NADAC in this Cecilia Garzella piece on ADHD drug shortages and their impact on patient access to treatment usatoday.com/story/news/inv…

account_circle
3 Axis Advisors(@3AxisAdvisors) 's Twitter Profile Photo

Check out Antonio Ciaccia’s thoughts in The New York Times about the CVS announcement of a new program that will alter the way they price medicines – but may not actually change their underlying finances nor eliminate the dysfunction that continues to plague the industry nytimes.com/2023/12/05/bus…

account_circle